Clinical Study of AFN50 Injection in the Autoimmune Diseases

NCT07408336 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

AlphaNa Bioscience Company Limited

Collaborators